FDA panel backs approval of GSK asthma drug in adults – Reuters


Reuters

FDA panel backs approval of GSK asthma drug in adults
Reuters
An advisory committee to the U.S. Food and Drug Administration recommended approval on Thursday of GlaxoSmithKline Plc's drug mepolizumab for severe asthma in patients aged 18 and older. The panel voted 10 to 4 against approving it in children aged …
UPDATE: Glaxo's (GSK) Severe Asthma Drug Mepolizumab Found Effective in StreetInsider.com
FDA committee recommends approval of Nucala for adults with severe asthmaHealio

all 8 news articles »

View full post on asthma – Google News

Weight loss reduces asthma severity in obese adults, finds study – News-Medical.net


News-Medical.net

Weight loss reduces asthma severity in obese adults, finds study
News-Medical.net
A Canadian study published in the June issue of the journal CHEST found weight loss reduced asthma severity as measured by airway hyperresponsiveness (AHR) in obese adults. The incidence of asthma is 1.47 times higher in obese people than …
Weight loss can reduce asthma severity in obese adultsEconomic Times

all 10 news articles »

View full post on asthma – Google News

Public Release: 8-Jun-2015 Study finds weight loss in obese adults can reduce … – EurekAlert (press release)

Public Release: 8-Jun-2015 Study finds weight loss in obese adults can reduce
EurekAlert (press release)
Glenview, Ill. (June 8, 2015)– A Canadian study published in the June issue of the journal CHEST found weight loss reduced asthma severity as measured by airway hyperresponsiveness (AHR) in obese adults. The incidence of asthma is 1.47 times higher in …

View full post on asthma – Google News

Spirometry underutilized for asthma management in U.S. adults – News-Medical.net


News-Medical.net

Spirometry underutilized for asthma management in U.S. adults
News-Medical.net
Researchers from the University of Texas Medical Branch at Galveston have found, for the first time, that spirometry was underutilized for asthma diagnosis and management in U.S. adults from 2001 to 2011, despite it's accuracy, cost effectiveness and
UTMB study shows cost-effective, expert recommended asthma test HealthCanal.com

all 3 news articles »

View full post on asthma – Google News

FDA Okays Breo Ellipta for Asthma in Adults – Medscape


Medscape

FDA Okays Breo Ellipta for Asthma in Adults
Medscape
The US Food and Drug Administration (FDA) has approved the combination of fluticasone furoate/vilanterol (Breo Ellipta, GlaxoSmithKline/Theravance) for the once-daily treatment of asthma in adults aged 18 years and older. Fluticasone furoate (FF) is an …
FDA approves Glaxo, Theravance's Breo Ellipta asthma drugReuters
Glaxo Wins U.S. Approval to Sell Breo Only to Adults With AsthmaBloomberg
FDA approves BREO® ELLIPTA® for the treatment of adults with asthma in the USMarketWatch
Science Recorder
all 48 news articles »

View full post on asthma – Google News

Work-Related Asthma Affects Millions of U.S. Adults: CDC – Philly.com


Youth Health Magzine

Work-Related Asthma Affects Millions of U.S. Adults: CDC
Philly.com
Almost 16 percent of American adults with asthma either developed the condition on the job or have asthma symptoms made worse by conditions in their workplace, said Dr. Jacek Mazurek, lead author of a new report from the U.S. Centers for Disease
CDC Says Work-Related Asthma Is CommonYouth Health Magzine

all 7 news articles »

View full post on asthma – Google News